Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT01608750
Other study ID # B.30.2.BAV.0.05.05/331
Secondary ID
Status Not yet recruiting
Phase Phase 4
First received May 28, 2012
Last updated May 30, 2012
Start date June 2012
Est. completion date June 2013

Study information

Verified date May 2012
Source Bezmialem Vakif University
Contact n/a
Is FDA regulated No
Health authority Turkey: Ministry of Health
Study type Interventional

Clinical Trial Summary

The aim of our study is to evaluate the effectiveness of proton pump inhibitor (PPI) treatment in patients with functional dyspepsia.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 200
Est. completion date June 2013
Est. primary completion date December 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- aged 18-45 years with symptoms of dyspepsia,

- no evidence of organic disease.

Exclusion Criteria:

- Patients with alarm symptoms,

- Severe concomitant illness,

- Pregnancy or lactation,

- Alcohol or drug abuse,

- Use of aspirin or other non-steroidal anti-inflammatory drugs antibiotics, H2 receptor blockers, bismuth, or proton pump inhibitors in the preceding two weeks

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Pantoprazol
40mg/day, oral, 28 days
Folic Acid
5 mg/day, oral, 28 days

Locations

Country Name City State
Turkey Bezmialem medical faculty Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Bezmialem Vakif University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Effectiveness of pantoprazole treatment in patients with functional dyspepsia measured by symptoms scale. one year No
See also
  Status Clinical Trial Phase
Completed NCT00358410 - An Exploratory Study Examining The Effects Of Taking GW679769 Once-Daily For 4 Days In Patients With Functional Dyspepsia Phase 2